Punit Dhillon

Member Since 2021

Punit Dhillon

President, CEO and Chair

Skye Bioscience Inc.

San Diego Area

Punit Dhillon is the Chairman and CEO of Skye Bioscience Inc., a public pharmaceutical company. He is the Co-founder, former President, and CEO of OncoSec, a biotechnology company pioneering new technologies to fight cancer, and the Co-founder of the registered charity, YELL Canada. Punit has been recognized as one of PharmaVOICE 100’s top CEOs and as a finalist for the EY Entrepreneur Of The Year™. He lives in San Diego with his wife, Nina, and their two daughters.

SKILLS

  • Biotechnology
  • Biopharmaceuticals
  • Leadership

RECENT CONTENT

March 14th, 2023

‘Fake It’ and You Might Never Make It

In the business world, it’s not always easy to recognize when “faking it” crosses the line.

November 22nd, 2022

Why Dominating Your Field Is a Marathon, Not a Sprint

What leaders at the most successful companies in the world have realized is that dominating your field over a long period requires a similarly long-term perspective. 

December 29th, 2021

How to Stay Competitive Without Letting Comparisons Become a Distraction

As a leader, it’s up to you to coach your team to victory.

October 1st, 2021

Don't Let Past Mistakes Hold You Back From Future Successes

Whether in athletics, work or life, not everything you do will end in a podium finish.

August 26th, 2021

3 Steps to Get Your Business Back on Track After the Pandemic

Don’t miss the opportunity to plan now to prepare for the next crisis.

August 13th, 2021

Trying to Better Your Branding? 12 Companies That Really Nailed It

These brands are great examples of how to tell your story right.

August 2nd, 2021

How to Adopt a Marathon Mindset to Reach Your Project’s Distant Finish Line

What exactly is a marathon mindset?

COMPANY INFO

Skye Bioscience Inc.

We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs. Our innovative approach to drug development enables us to transform cannabinoids into safer, more effective pharmaceutical agents. By advancing our novel drugs, we are working to bring important new medicines to market by unlocking the potential of cannabinoids.

INDUSTRY

Technology

© 2023 Culture Council, LLC. All rights reserved. | Terms and Conditions and Privacy Policy | Rolling Stone® and the other denoted terms and the related trade dress are a non-exclusive list of the trademarks of Culture Council, LLC. in the U.S. and/or other countries. Culture Council, LLC trademarks and trade dress may not be used in connection with any product or service that is not Culture Council, LLC, in any manner that is likely to cause confusion among customers, or any manner that disparages Culture Council, LLC. This site contains the trademarks, service marks, and logos of third parties and such trademarks and service marks are the property of their respective owners and not owned by Culture Council, LLC. Such third party trademark owners may or may not be affiliated with, connected to, or sponsored by Culture Councils, LLC. These third party marks include but are not limited to Rolling Stone®, which is a registered trademark of and the property of Rolling Stone, LLC.